Results 151 to 160 of about 436,478 (164)

Disorders of the JAK/STAT Pathway in T Cell Lymphoma Pathogenesis: Implications for Immunotherapy*

Annual Review of Immunology, 2017

exaly  

Inteferons pen the JAK–STAT pathway

Seminars in Cell and Developmental Biology, 2008
Christian W Schindler
exaly  

JAK Inhibitors: Prospects in Connective Tissue Diseases

Clinical Reviews in Allergy and Immunology, 2020
Hanxiao You, Jiuliang Zhao, Xiaofeng Zeng   +2 more
exaly  

JAK/STAT3-Regulated Fatty Acid β-Oxidation Is Critical for Breast Cancer Stem Cell Self-Renewal and Chemoresistance

Cell Metabolism, 2018
Yuan Yuan, Jieun Song, Samir M Hanash
exaly  

JAK/STAT – Emerging Players in Metabolism

Trends in Endocrinology and Metabolism, 2018
Minna Woo, David W Dodington
exaly  

JAK inhibitors in dermatology: The promise of a new drug class

Journal of the American Academy of Dermatology, 2017
Brett King, William Damsky
exaly  

The regulation of JAKs in cytokine signaling and its breakdown in disease

Cytokine, 2019
Henrik Hammarén, Olli Silvennoinen
exaly  

People also looked at

Frontiers in Oncology, 2018
Emira Bousoik, Hamidreza Montazeri Aliabadi, Montazeri Aliabadi Hamidreza   +2 more
exaly  

Biology and significance of the JAK/STAT signalling pathways

Growth Factors, 2012
Sandra E Nicholson, Hiu Kiu
exaly  

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature Reviews Clinical Oncology, 2018
Jennifer Rubin Grandis, Daniel E Johnson
exaly